Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Non Operating Income: 2009-2025

Historic Non Operating Income for Cytokinetics (CYTK) over the last 16 years, with Sep 2025 value amounting to $10.2 million.

  • Cytokinetics' Non Operating Income fell 39.91% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $52.0 million, marking a year-over-year increase of 17.82%. This contributed to the annual value of $51.5 million for FY2024, which is 86.52% up from last year.
  • Latest data reveals that Cytokinetics reported Non Operating Income of $10.2 million as of Q3 2025, which was down 21.18% from $13.0 million recorded in Q2 2025.
  • Over the past 5 years, Cytokinetics' Non Operating Income peaked at $17.1 million during Q3 2024, and registered a low of -$377,000 during Q4 2021.
  • Moreover, its 3-year median value for Non Operating Income was $10.2 million (2025), whereas its average is $10.6 million.
  • Per our database at Business Quant, Cytokinetics' Non Operating Income slumped by 117.57% in 2021 and then spiked by 1,693.94% in 2022.
  • Over the past 5 years, Cytokinetics' Non Operating Income (Quarterly) stood at -$377,000 in 2021, then surged by 1,670.03% to $5.9 million in 2022, then climbed by 28.16% to $7.6 million in 2023, then soared by 97.92% to $15.0 million in 2024, then plummeted by 39.91% to $10.2 million in 2025.
  • Its last three reported values are $10.2 million in Q3 2025, $13.0 million for Q2 2025, and $13.7 million during Q1 2025.